BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Feb. 12, 2004
View Archived Issues
What Motivates Cancer Patients To Enroll Voluntarily In Clinical Trials? Do They Improve Health Outcomes?
Read More
New BIO Conference Welcomes Small, Mid-Caps In 'H&Q' Style
Read More
Other News To Note
Read More
Appointments And Advancements
Read More
InterMune To Restructure Debt With $150M Notes Placement
InterMune Inc. raised $150 million in a private placement of convertible senior notes as part of a plan to reduce its burn rate and narrow its focus in two therapeutic areas. (BioWorld Today)
Read More
Corcept Tries Again: Company Files For Estimated $80M IPO
Read More